Current evidence on the circadian-time-dependent effects of hypertension medications and their combinations in relation to findings of MAPEC and Hygia Chronotherapy Trial.

Chronobiology International
Ramón C HermidaArtemio Mojón

Abstract

The main purpose of this commentary is to update, based on our extensive review of the published literature of the past 45 yrs, the differential therapeutic effects of hypertension medications of various classes and their combinations when ingested in the evening/at-bedtime versus in the morning/upon-awakening. Interestingly, revision of the currently available evidence on the differential circadian-time-dependent effects of hypertension medications of six different classes and their combinations indicates among the 137 published hypertension medication trials that evaluated blood pressure (BP)-lowering efficacy according to treatment-time, 112 (81.75%) documented significant better benefits by evening/bedtime compared to morning/awakening-scheduled therapy. The remaining 25 published trials found no treatment-time difference in effects; indeed, no single study has reported better benefits of the still conventional, but scientifically unjustified, morning than evening/at-bedtime treatment scheme.

References

Mar 10, 2001·Eating and Weight Disorders : EWD·N A EllimanW K Wan
Mar 25, 2010·BMJ : British Medical Journal·Kenneth F SchulzUNKNOWN CONSORT Group
Sep 22, 2010·Chronobiology International·Ramón C HermidaJosé R Fernández
Sep 22, 2010·Chronobiology International·Francesco Portaluppi, Michael H Smolensky
Oct 7, 2011·The Cochrane Database of Systematic Reviews·Ping ZhaoZhengrong Wang
Oct 20, 2012·Chronobiology International·Ramón C HermidaFrancesco Portaluppi
Feb 22, 2013·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Mitsuru OhishiHiromi Rakugi
Apr 25, 2013·European Journal of Internal Medicine·Alfredo De GiorgiRoberto Manfredini
Dec 1, 2012·Therapeutic Advances in Drug Safety·Basil N OkeahialamJayne Na Ajuluchukwu
Oct 25, 2014·Current Pharmaceutical Design·Michael H SmolenskyFrancesco Portaluppi
Dec 18, 2014·The Annals of Pharmacotherapy·Paul M StrangesAmie D Brooks
Sep 25, 2015·Diabetologia·Ramón C HermidaJosé R Fernández
Sep 25, 2015·Clinical Trials : Journal of the Society for Clinical Trials·Scott Y H Kim, Franklin G Miller
Dec 25, 2016·BMJ : British Medical Journal
Apr 1, 2017·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Gervase Vernon
May 8, 2018·The Canadian Journal of Cardiology·Kara A NerenbergUNKNOWN Hypertension Canada
Aug 15, 2018·European Heart Journal·Ramón C HermidaUNKNOWN Hygia Project Investigators
Sep 30, 2018·Current Hypertension Reports·N P BowlesS A Shea
Aug 4, 2019·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Satoshi UmemuraNobuhito Hirawa
Oct 24, 2019·European Heart Journal·Ramón C HermidaUNKNOWN Hygia Project Investigators
Jan 30, 2020·BMJ Evidence-based Medicine·Carl HeneghanKamal R Mahtani
Feb 6, 2020·European Journal of Preventive Cardiology·Rahul GuptaWilbert S Aronow
Mar 28, 2020·International Journal of Clinical Pharmacology and Therapeutics·Kristina MosnaPavel Babal
Apr 24, 2020·The American Journal of Medicine·Samer Ellahham
May 19, 2020·Chronobiology International·Björn Lemmer, Martin Middeke

❮ Previous
Next ❯

Citations

Sep 2, 2020·Chronobiology International·Björn Lemmer, Martin Middeke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.